Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
FDA/EMA/Drug Designation
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft Survival of 89% After Imlifdase Treatment and Transplantation
Biospace News
-
March 6, 2020
FDA/EMA/Drug Designation
Orexo Submits Application for vorvida to the FDA to Enable Commercialization in the US
FDA/EMA/Drug Designation
TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Follicular Lymphoma
FDA/EMA/Drug Designation
Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis
FDA/EMA/Drug Designation
FDA Greenlights Sanofi’s Sarclisa for Multiple Myeloma
FDA/EMA/Drug Designation
Shionogi Receives Positive CHMP Opinion for FETCROJA (cefiderocol) for the Treatment...
Firstwordpharma News
-
March 2, 2020
0
FDA/EMA/Drug Designation
European Medicines Agency Grants PRIME and Advanced Therapy Medicinal Product Designations...
Firstwordpharma News
-
March 2, 2020
0
FDA/EMA/Drug Designation
Eli Lilly’s Cyramza Passes FDA Advisory Hurdle for NSCLC
Biospace News
-
February 27, 2020
0
FDA/EMA/Drug Designation
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation...
Firstwordpharma News
-
February 27, 2020
0
FDA/EMA/Drug Designation
FDA advisory panel narrowly backs use of Eli Lilly’s Cyramza for...
Firstwordpharma News
-
February 27, 2020
0
1
2
3
...
50
Page 1 of 50
- Advertisement -
MOST POPULAR
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
January 29, 2019
A Single Course of Provention’s PRV-031 (Teplizumab) Delays Type 1 Diabetes...
June 9, 2019
HPV immunization program cuts pre-cancer rates by more than half
October 21, 2019
Cocktail of common antibiotics can fight resistant E. coli
February 20, 2019
Load more
HOT NEWS
Commercial
Dyne Therapeutics Launches With $50 Million Series A to Treat Muscle...
Others
BioSpace Global Roundup, Dec. 19
Commercial
Mallinckrodt plc To Report Earnings Results For First Quarter 2019
Approval
GSK’s Zejula Widens the PARP Scope with New FDA Approval
